EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors

Mohammad M Al-Sanea, Hani M Hafez, Ahmed A B Mohamed, Hamed W El-Shafey iD, Abdullah A Elgazar iD, Samar S Tawfik, Wafaa A Ewes, Shaimaa Hussein, Tariq G Alsahli, Abdelrahman Hamdi

Drug Design, Development and Therapy · 2024

DOI: 10.2147/dddt.s490930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Mohammad M Al-Sanea und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Aljouf, 72388, Saudi Arabia. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Antineoplastic Agents, Drug Screening Assays, Antitumor, Drug Design. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsDrug Screening Assays, AntitumorDrug DesignCell ProliferationProtein Kinase InhibitorsMolecular Docking SimulationDose-Response Relationship, DrugQuinazolinonesHumansStructure-Activity RelationshipMolecular StructureUreaApoptosis

Stichwörter der Autor:innen

VEGFR-2 inhibitorsapoptosiscell cycle analysismolecular dockingquinazolines

Substanzen

Vascular Endothelial Growth Factor Receptor-2Antineoplastic AgentsKDR protein, humanProtein Kinase InhibitorsQuinazolinonesUrea

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, Jouf University, Sakaka, Aljouf, 72388, Saudi Arabia.
  • Pharmaceutical Chemistry Department, College of Pharmacy, Al-Esraa University, Baghdad, Iraq.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
  • Department of Pharmacognosy, Faculty of Pharmacy, Kafrelsheikh University, Kafr El Sheikh, Egypt.
  • Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Aljouf, 72388, Saudi Arabia.

ORCID-Profile: Hamed W El-Shafey, Abdullah A Elgazar

Zitieren

APA

Al-Sanea, M. M., Hafez, H. M., Mohamed, A. A. B., El-Shafey, H. W., Elgazar, A. A., Tawfik, S. S., Ewes, W. A., Hussein, S., Alsahli, T. G., & Hamdi, A. (2024). Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s490930

Vancouver

Al-Sanea MM, Hafez HM, Mohamed AAB, El-Shafey HW, Elgazar AA, Tawfik SS, et al. Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s490930

BibTeX
@article{AlSanea2024,
  author = {Al-Sanea, Mohammad M and Hafez, Hani M and Mohamed, Ahmed A B and El-Shafey, Hamed W and Elgazar, Abdullah A and Tawfik, Samar S and Ewes, Wafaa A and Hussein, Shaimaa and Alsahli, Tariq G and Hamdi, Abdelrahman},
  title = {Design, Synthesis, Pharmacological Evaluation of Quinazolin-4(3H)-Ones Bearing Urea Functionality as Potential VEGFR-2 Inhibitors},
  journal = {Drug Design, Development and Therapy},
  year = {2024},
  doi = {10.2147/dddt.s490930}
}
Kostenlos starten →